Publication:
The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus.

dc.contributor.authorSanabria-de la Torre, Raquel
dc.contributor.authorGarcia-Fontana, Cristina
dc.contributor.authorGonzalez-Salvatierra, Sheila
dc.contributor.authorAndujar-Vera, Francisco
dc.contributor.authorMartinez-Heredia, Luis
dc.contributor.authorGarcia-Fontana, Beatriz
dc.contributor.authorMuñoz-Torres, Manuel
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderEuropean Regional Development Fund (FEDER)
dc.contributor.funderJunta de Andalucía
dc.contributor.funderUniversity of Granada
dc.date.accessioned2023-05-03T14:01:59Z
dc.date.available2023-05-03T14:01:59Z
dc.date.issued2022-06-21
dc.description.abstractVascular complications are the leading cause of morbidity and mortality among patients with type 2 diabetes mellitus (T2DM). These vascular abnormalities result in a chronic hyperglycemic state, which influences many signaling molecular pathways that initially lead to increased oxidative stress, increased inflammation, and endothelial dysfunction, leading to both microvascular and macrovascular complications. Endothelial dysfunction represents the initial stage in both types of vascular complications; it represents "mandatory damage" in the development of microvascular complications and only "introductory damage" in the development of macrovascular complications. Increasing scientific evidence has revealed an important role of the Wnt pathway in the pathophysiology of the vascular wall. It is well known that the Wnt pathway is altered in patients with T2DM. This review aims to be an update of the current literature related to the Wnt pathway molecules that are altered in patients with T2DM, which may also be the cause of damage to the vasculature. Both microvascular complications (retinopathy, nephropathy, and neuropathy) and macrovascular complications (coronary artery disease, cerebrovascular disease, and peripheral arterial disease) are analyzed. This review aims to concisely concentrate all the evidence to facilitate the view on the vascular involvement of the Wnt pathway and its components by highlighting the importance of exploring possible therapeutic strategy for patients with T2DM who develop vascular pathologies.
dc.description.sponsorshipThis research was funded by Instituto de Salud Carlos III grants (PI18-00803, PI21-01069, and PI18-01235), co-funded by the European Regional Development Fund (FEDER) and by a Junta de Andalucía grant (PI-0268-2019). In addition, R.S.-T. was funded by the University of Granada with co-funding by FEDER, (grant number 8110), and C.G.-F. and S.G.-S. were funded by a postdoctoral fellowship (CD20/00022) and a predoctoral fellowship (FI19/00118), respectively, from the Instituto de Salud Carlos III.
dc.description.versionSi
dc.identifier.citationSanabria-de la Torre R, García-Fontana C, González-Salvatierra S, Andújar-Vera F, Martínez-Heredia L, García-Fontana B, , et al. The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus. Int J Mol Sci. 2022 Jun 23;23(13):6995.
dc.identifier.doi10.3390/ijms23136995
dc.identifier.essn1422-0067
dc.identifier.pmcPMC9266892
dc.identifier.pmid35805996
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266892/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1422-0067/23/13/6995/pdf?version=1656065275
dc.identifier.urihttp://hdl.handle.net/10668/21170
dc.issue.number13
dc.journal.titleInternational journal of molecular sciences
dc.journal.titleabbreviationInt J Mol Sci
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number20
dc.publisherMDPI AG
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.projectIDPI18-00803
dc.relation.projectIDPI21-01069
dc.relation.projectIDPI18-01235
dc.relation.projectIDPI-0268-2019
dc.relation.projectID8110
dc.relation.publisherversionhttps://www.mdpi.com/resolver?pii=ijms23136995
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectWnt pathway
dc.subjectcardiovascular disease
dc.subjectmacrovascular disease
dc.subjectmicrovascular disease
dc.subjecttype 2 diabetes mellitus
dc.subject.decsDiabetes Mellitus Tipo 2
dc.subject.decsEnfermedad arterial
dc.subject.decsPeriférica
dc.subject.decsEnfermedades cardiovasculares
dc.subject.decsSistema cardiovascular
dc.subject.meshCardiovascular Diseases
dc.subject.meshCardiovascular System
dc.subject.meshDiabetes Complications
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshHumans
dc.subject.meshPeripheral Arterial Disease
dc.subject.meshWnt Signaling Pathway
dc.titleThe Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number23
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9266892.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format